Biodeal Pharmaceuticals Raises ₹385 Crore From RMB Capitalworks For Expansion And R&D
Mumbai, August 10, 2026: Biodeal Pharmaceuticals on Monday announced a Rs 385 crore investment from RMB Capitalworks for business expansion and research and development activities. This is the first equity raise by the two-decade-old Biodeal, a contract development and manufacturing organisation. RMB, a unit of South African lender FirstRand Bank, will get an undisclosed stake in the company.…
We haven't written up this one. Free Press Journal has the full story — the link below goes straight to it.
